[
  {
    "ts": null,
    "headline": "AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.",
    "url": "https://finnhub.io/api/news?id=107003600f49c001593d12e74168a469f08a573a88968d3f853d945a9beeea16",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759262748,
      "headline": "AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know",
      "id": 136944071,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.",
      "url": "https://finnhub.io/api/news?id=107003600f49c001593d12e74168a469f08a573a88968d3f853d945a9beeea16"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Climb Late Afternoon",
    "summary": "Health care stocks advanced late Tuesday afternoon, with the NYSE Health Care Index adding 2.5% and",
    "url": "https://finnhub.io/api/news?id=26948ee153551d9c68e40fca5a2f473c50dc0e50fb3bcaf5279c1d50f3af4b1e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759261034,
      "headline": "Sector Update: Health Care Stocks Climb Late Afternoon",
      "id": 136944072,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Health care stocks advanced late Tuesday afternoon, with the NYSE Health Care Index adding 2.5% and",
      "url": "https://finnhub.io/api/news?id=26948ee153551d9c68e40fca5a2f473c50dc0e50fb3bcaf5279c1d50f3af4b1e"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Begins Construction on $70 Million Expansion to Further Increase Biologics Manufacturing and R&D Presence in the U.S.",
    "summary": "AbbVie (NYSE: ABBV) today announced the start of construction of a $70 million expansion at its AbbVie Bioresearch Center (ABC) in Worcester, Mass., which serves as a center of excellence for biologics research and development and manufacturing. This expansion is part of the company's previously announced commitment to invest more than $10 billion of capital in the U.S. to broadly support innovation and expand critical biologics manufacturing capabilities and capacity.",
    "url": "https://finnhub.io/api/news?id=2df764ca43b1e2bc27c84b08310f534a4d06a5ddb3319386f79cdc3732ab8e52",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759258800,
      "headline": "AbbVie Begins Construction on $70 Million Expansion to Further Increase Biologics Manufacturing and R&D Presence in the U.S.",
      "id": 136944073,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (NYSE: ABBV) today announced the start of construction of a $70 million expansion at its AbbVie Bioresearch Center (ABC) in Worcester, Mass., which serves as a center of excellence for biologics research and development and manufacturing. This expansion is part of the company's previously announced commitment to invest more than $10 billion of capital in the U.S. to broadly support innovation and expand critical biologics manufacturing capabilities and capacity.",
      "url": "https://finnhub.io/api/news?id=2df764ca43b1e2bc27c84b08310f534a4d06a5ddb3319386f79cdc3732ab8e52"
    }
  },
  {
    "ts": null,
    "headline": "3 Companies That May Be Priced Below Their Estimated Value",
    "summary": "As the United States stock market navigates uncertainties such as potential government shutdowns and fluctuating commodity prices, major indices like the Dow Jones, Nasdaq, and S&P 500 have shown resilience with recent gains. In this environment, identifying undervalued stocks can be crucial for investors seeking opportunities that may offer value beyond current market perceptions.",
    "url": "https://finnhub.io/api/news?id=00350a6c9c0cb399c7d73450f4cb846294870b6db5c1a5c542d9d09849af0cc1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759253881,
      "headline": "3 Companies That May Be Priced Below Their Estimated Value",
      "id": 136944074,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "As the United States stock market navigates uncertainties such as potential government shutdowns and fluctuating commodity prices, major indices like the Dow Jones, Nasdaq, and S&P 500 have shown resilience with recent gains. In this environment, identifying undervalued stocks can be crucial for investors seeking opportunities that may offer value beyond current market perceptions.",
      "url": "https://finnhub.io/api/news?id=00350a6c9c0cb399c7d73450f4cb846294870b6db5c1a5c542d9d09849af0cc1"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=fbdedc98ffa4064dbd05e6873216dae2f5d6ede1258bb54da1575039308d8c92",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759249860,
      "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "id": 136995802,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=fbdedc98ffa4064dbd05e6873216dae2f5d6ede1258bb54da1575039308d8c92"
    }
  },
  {
    "ts": null,
    "headline": "Abbvie Building $70M Expansion at Massachusetts Bioresearch Center",
    "summary": "Abbvie Building $70M Expansion at Massachusetts Bioresearch Center",
    "url": "https://finnhub.io/api/news?id=08fd8eca154f6fc6aca6b900e30ad5bfc0c704b78c84e9359f6ec367a57de425",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759247700,
      "headline": "Abbvie Building $70M Expansion at Massachusetts Bioresearch Center",
      "id": 136995803,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "Abbvie Building $70M Expansion at Massachusetts Bioresearch Center",
      "url": "https://finnhub.io/api/news?id=08fd8eca154f6fc6aca6b900e30ad5bfc0c704b78c84e9359f6ec367a57de425"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock Rises After WSJ Reports Company Will Cut Drug Costs",
    "summary": "Pfizer shares rose 2.8% Wednesday midday after The Wall Street Journal reported the pharmaceutical company would unveil a plan, alongside the Trump administration, to cut drug costs later Tuesday. Here's what to know:    The White House also plans to unveil a direct-to-consumer website for Americans to buy medication.",
    "url": "https://finnhub.io/api/news?id=6a633f4e3f072a0287e080921366b4652de528670a7645f164a019cf9fd539e4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759247240,
      "headline": "Pfizer Stock Rises After WSJ Reports Company Will Cut Drug Costs",
      "id": 136937619,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Pfizer shares rose 2.8% Wednesday midday after The Wall Street Journal reported the pharmaceutical company would unveil a plan, alongside the Trump administration, to cut drug costs later Tuesday. Here's what to know:    The White House also plans to unveil a direct-to-consumer website for Americans to buy medication.",
      "url": "https://finnhub.io/api/news?id=6a633f4e3f072a0287e080921366b4652de528670a7645f164a019cf9fd539e4"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Submits Biologics License Application (BLA) to U.S. FDA for Pivekimab sunirine (PVEK) - an Investigational Antibody-Drug Conjugate (ADC) to Treat Rare Cancer with Limited Treatment Options",
    "summary": "AbbVie (NYSE: ABBV) today announced submission of a new Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of investigational Pivekimab sunirine (PVEK) for treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). The submission is based on data from the Phase 1/2 CADENZA trial, a global study evaluating the safety and efficacy of PVEK in BPDCN. BPDCN is a rare and aggressive blood cancer that has features of both leukemia and lymphoma. Patie",
    "url": "https://finnhub.io/api/news?id=2e76c7fa6058cb583e8f1e578b36bc6278efe5aa57b87edcba1070e9d60ebfa4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759233600,
      "headline": "AbbVie Submits Biologics License Application (BLA) to U.S. FDA for Pivekimab sunirine (PVEK) - an Investigational Antibody-Drug Conjugate (ADC) to Treat Rare Cancer with Limited Treatment Options",
      "id": 136936106,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (NYSE: ABBV) today announced submission of a new Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of investigational Pivekimab sunirine (PVEK) for treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). The submission is based on data from the Phase 1/2 CADENZA trial, a global study evaluating the safety and efficacy of PVEK in BPDCN. BPDCN is a rare and aggressive blood cancer that has features of both leukemia and lymphoma. Patie",
      "url": "https://finnhub.io/api/news?id=2e76c7fa6058cb583e8f1e578b36bc6278efe5aa57b87edcba1070e9d60ebfa4"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Files for FDA OK of Pivekimab Sunirine in Rare Blood Cancer",
    "summary": "AbbVie Files for FDA OK of Pivekimab Sunirine in Rare Blood Cancer",
    "url": "https://finnhub.io/api/news?id=ef63d6863d02809955fc2e38294f0d9458df1b7036fe5fba708886aed58b3185",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759220640,
      "headline": "AbbVie Files for FDA OK of Pivekimab Sunirine in Rare Blood Cancer",
      "id": 136995804,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Files for FDA OK of Pivekimab Sunirine in Rare Blood Cancer",
      "url": "https://finnhub.io/api/news?id=ef63d6863d02809955fc2e38294f0d9458df1b7036fe5fba708886aed58b3185"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc.(ABBV) Unit Expands Skin Solution Availability amid $5.2B Opportunity",
    "summary": "AbbVie Inc. (NYSE:ABBV) is one of the best conservative stocks to buy now. On September 23, the company’s subsidiary, Allergan Aesthetics, announced the rollout of SKINVIVE by JUVÉDERM in 35 additional markets. With the expansion, the skin care solution is now available in 57 global markets. The expansion comes amid growing market demand for solutions […]",
    "url": "https://finnhub.io/api/news?id=0b2cce95883810498537822d20bb9a01e83d0d6bf2b3c91333bd7f992175c57f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759219236,
      "headline": "AbbVie Inc.(ABBV) Unit Expands Skin Solution Availability amid $5.2B Opportunity",
      "id": 136934076,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie Inc. (NYSE:ABBV) is one of the best conservative stocks to buy now. On September 23, the company’s subsidiary, Allergan Aesthetics, announced the rollout of SKINVIVE by JUVÉDERM in 35 additional markets. With the expansion, the skin care solution is now available in 57 global markets. The expansion comes amid growing market demand for solutions […]",
      "url": "https://finnhub.io/api/news?id=0b2cce95883810498537822d20bb9a01e83d0d6bf2b3c91333bd7f992175c57f"
    }
  }
]